Related Experiment Videos
Hemoperfusion study with carbamazepine in vitro
K Derzsiová1, M Mydlík, V Petríková
1Nephrological Clinic, University Hospital of L. Pasteur, Kosice, Slovak Republic.
The International Journal of Artificial Organs
|December 28, 1999
Summary
Amberlite XAD-2 and Amberlite XAD-4 sorbents effectively removed carbamazepine during hemoperfusion in vitro, with faster clearance in saline than plasma. These sorbents are recommended for acute carbamazepine poisoning.
Area of Science:
- Toxicology
- Biomedical Engineering
- Materials Science
Background:
- Carbamazepine overdose is a significant clinical challenge requiring effective detoxification strategies.
- Hemoperfusion is a potential extracorporeal treatment modality for drug intoxication.
- Evaluating sorbent efficacy is crucial for optimizing hemoperfusion therapy.
Observation:
- In vitro hemoperfusion experiments were conducted using active charcoal, Amberlite XAD-2, and Amberlite XAD-4 with carbamazepine in saline and human plasma.
- Carbamazepine concentrations were monitored over 5-hour perfusion periods.
- Complete carbamazepine removal was achieved within 120 minutes using Amberlite XAD-2 or XAD-4 in saline, and within 240 minutes in plasma.
Findings:
- Amberlite XAD-2 and Amberlite XAD-4 demonstrated superior carbamazepine sorption efficacy compared to active charcoal in vitro.
- Hemoperfusion with these Amberlite resins led to rapid clearance of carbamazepine from both saline and plasma.
- Successful in vivo application of Amberlite XAD-4 hemoperfusion resulted in the survival of a patient with acute carbamazepine intoxication.
Implications:
- Amberlite XAD-2 and Amberlite XAD-4 are highly effective sorbents for carbamazepine hemoperfusion.
- These findings support the use of Amberlite XAD-2 or XAD-4 hemoperfusion for managing acute carbamazepine poisoning in clinical settings.
- Further research may explore optimizing hemoperfusion protocols for various drug toxicities.